-
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. . http://lm360.us/Clarkson-son-of-Neibert-from-Valenca?Woodlinbr=186
marketwatch: "new migraine drugs have promise -- and a ,500 price tag." . .